Common Shares Outstanding: The number of class A shares currently held by investors.
Novo Nordisk A/S (NVO) Common Shares Outstanding data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$11.69B |
|
$4.03B |
|
$1.95B |
|
$9.74B |
|
$6.60B |
|
$5.09B |
|
$54.15M |
|
$5.14B |
|
$5.14B |
|
$4.03B |
|
$4.03B |
|
$4.03B |
|
$4.03B |
|
$5.09B |
|
$5.86B |
|
4.44B |
|
4.45B |
|
$0.91 |
|
$0.91 |
|
| Balance Sheet Financials | |
$24.75B |
|
$27.49B |
|
$48.59B |
|
$73.34B |
|
$31.56B |
|
$13.28B |
|
$16.21B |
|
$47.77B |
|
$25.56B |
|
$9.16B |
|
$25.56B |
|
|
Common Shares Outstanding |
-- |
| Cash Flow Statement Financials | |
$9.94B |
|
$-3.18B |
|
$-6.20B |
|
$2.38B |
|
$2.80B |
|
$422.84M |
|
-- |
|
$-5.34B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
0.34 |
|
0.59 |
|
83.29% |
|
43.52% |
|
43.52% |
|
-- |
|
43.98% |
|
34.48% |
|
$5.67B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.28 |
|
0.90 |
|
100.52 |
|
15.77% |
|
44.02% |
|
5.50% |
|
10.38% |
|
-- |
|
$1.28 |
|
$2.24 |
|